STAR and breast neoplasm: In addition, we demonstrate suppression of StAR expression, along with E2 biosynthesis, by a variety of HDACIs, not only in hormone-sensitive human MCF7 cells, but also in primary cultures of breast tumor epithelial cells, highlighting therapeutic relevance of StAR as a drug target for treatment of ER+/PR+ BCs.